CFCThe Compounder Score
ALGN logo

ALGN — Align Technology, Inc.

Medical Instruments & SuppliesHealthcare

$168.32

+$1.35 (+0.81%)

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.

Market Cap

$11.86B

Forward P/E

13.7x

52-Week Range

N/A

ALGN Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$4B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$491M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

13.6%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

2.9x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

2.5%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

-3.2%

Net buyback · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).